Skip to main content
Toggle navigation
Search
Home
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
P
Paglialunga, Sabina
Celerion
PII-014
-
SAFETY , TOLERABILITY, AND PHARMACOKINETICS OF SM17 IN HEALTHY VOLUNTEERS, A NOVEL IL-17 RECEPTOR B TARGETING ANTIBODY IN PHASE I DEVELOPMENT FOR THE TREATMENT OF ASTHMA
Sabina Paglialunga
Favorite
Pal, Arindom
U.S. Food and Drug Administration
PI-099
-
PBPK MODELING TO SUPPORT THE EXPANSION OF BIOWAIVER TO NON-Q1/Q2 BCS CLASS III DRUG PRODUCTS.
Arindom Pal
Favorite
Paleja, Bhairav
VANTAGE RESEARCH
E-003
-
A QUANTITATIVE SYSTEMS PHARMACOLOGY QSP) MODEL FRAMEWORK FOR COMBINED CLINICAL EFFICACY AND HEMATOLOGICAL TOXICITY PRECITIONS FOR ANTIBODY DRUG CONJUGATES.
Bhairav Paleja
Favorite
E-004
-
DEVELOPMENT OF QSP PLATFORM MODEL FOR PREDICTING CLINICAL EFFICACY AND CRS INCIDENCE OF CD3 BISPECIFICS IN STEAP1 PROSTATE CANCER
Bhairav Paleja
Favorite
Pan, Xian
Certara
PII-097
-
MECHANISTIC INSIGHTS INTO CYTOKINE ANTAGONIST-DRUG INTERACTIONS: A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING APPROACH WITH TOCILIZUMAB AS A CASE STUDY
Xian Pan
Favorite
Paydary, Koosha
Rush University Medical Center, Department of Medicine, Section of Hematology, Oncology and Cell Therapy
PII-037
-
REAL-WORLD CHARACTERIZATION OF DRUG-DRUG INTERACTIONS AMONG PATIENTS WITH ONCOGENE-DRIVEN NON-SMALL CELL LUNG CANCER USING TYROSINE KINASE INHIBITORS
Koosha Paydary
Favorite
Pillay-Fuentes Lorente, Veshni
Division of Clinical Pharmacology, Department of Medicine, Stellenbosch University
PI-060
-
CHARACTERIZING COLISTIN PHARMACOKINETICS FOLLOWING A LOADING DOSE: FIRST DESCRIPTION IN AN AFRICAN COHORT.
Veshni Pillay-Fuentes Lorente
Favorite
Piscitelli, Joseph
Pfizer, Inc.
PI-010
-
LIMITED SAMPLING STRATEGIES FOR NONCOMPARTMENTAL ANALYSES OF ENCORAFENIB PHARMACOKINETIC DATA
Joseph Piscitelli
Favorite
PI-036
-
POPULATION PHARMACOKINETIC MODELING OF SUNITINIB AND SU12662 IN PATIENTS WITH SOLID TUMORS
Joseph Piscitelli
Favorite
Purohit, Dvijen
University of California, San Francsico
PI-015
-
IMPACT OF RIFAMPICIN DOSE ON LINEZOLID PHARMACOKINETICS IN TUBERCULOUS MENINGITIS: INSIGHTS FROM THE ALTER TRIAL
Dvijen Purohit
Favorite